VERU INC. Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount
VERU INC. (VERU) reported Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount of $13.34 thousand for the 12-month period ending 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Notes › Income Taxes
us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount · last filed 2024-12-16
- VERU INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2024-06-30 was $309.00.
- VERU INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2023-06-30 was $0.00.
- VERU INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2023-03-31 was -$19.89K.
- VERU INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for the quarter ending 2022-12-31 was $83.74K.
- VERU INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2024 was $13.34K, a 92.62% decline from fiscal 2023.
- VERU INC. effective income tax rate reconciliation, tax expense (benefit), share-based payment arrangement, amount for fiscal 2023 was $180.85K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount 12 month |
|---|---|---|---|---|
| 2024-09-30 | $13.34K 10-K · filed 2024-12-16 | |||
| 2024-06-30 | $309.00 10-Q · filed 2024-08-08 | $309.00 10-Q · filed 2024-08-08 | ||
| 2023-09-30 | $180.85K 10-K · filed 2024-12-16 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $63.85K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | -$19.89K 10-Q · filed 2024-05-08 | $63.85K 10-Q · filed 2024-05-08 | ||
| 2022-12-31 | $83.74K 10-Q · filed 2024-04-01 | |||
| 2022-06-30 | -$147.57K 10-Q/A · filed 2023-11-15 | -$170.92K 10-Q/A · filed 2023-11-15 | ||
| 2022-03-31 | -$23.35K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$23.35K 10-Q · filed 2023-02-09 | |||
| 2021-06-30 | $53.01K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $11.28K 10-Q · filed 2022-05-12 | -$53.01K 10-Q · filed 2022-05-12 | ||
| 2020-12-31 | -$64.29K 10-Q · filed 2022-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |